id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1445166,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,MMM,"Budget and deficit reduction proposals that may affect the Medicare and Medicaid programs, including issues related to End Stage Renal Disease, and Sustainable Growth Rate and Average Sales Price calculations.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00